STAT+: Anthos stroke drug appears safer than common blood thinner in mid-stage trial
STAT
NOVEMBER 12, 2023
PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients. Continue to STAT+ to read the full story…
Let's personalize your content